|
Thursday 9th February 2012 |
Text too small? |
Fisher & Paykel Healthcare said it has renewed an exclusive US distribution agreement with global medical technology company CareFusion for a further three years.
Fisher & Paykel's president of US operations, Justin Callahan, said his company's continued partnership with CareFusion will help it to continue to grow in the US.
A CareFusion segment president, Vivek Jain, said his company and Fisher & Paykel Healthcare have been partners in bringing the latter's portfolio of respiratory consumable products to US hospitals for more than 25 years.
“As we extend and strengthen our strategic relationships with proven partners like Fisher & Paykel Healthcare, our customers benefit from continued access to market-leading technologies that help improve the cost, quality and safety of patient care,” Jain said.
In the year ended March 2011, North American sales accounted for 46 percent of Fisher & Paykel Healthcare's total sales.
Fisher & Paykel Healthcare's shares, which tend to suffer when the New Zealand dollar is strong, closed yesterday at $2.11. That's just above its year-low at $2.09 struck last month and well down from the high at $3.19 early last year.
(BusinessDesk)
BusinessDesk.co.nz
No comments yet
HGH Ltd Results for the 6 months ended 1 February 2026
March 27th Morning Report
CDC investor presentation and guidance update
PFI - Potential Bond Offer by PFI
MCY - Mercury Green Bond offer - interest rate set
March 25th Morning Report
AFT - Chief Financial Officer update
KMD Brands: Response to Stokehouse transaction concept
March 24th Morning Report
MCY - Mercury launches retail Green Bond offer